Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New technologies in interventional cardiology.

N A Chronos1, U Sigwart

  • 1Royal Brompton National Heart and Lung Hospital, London, UK.

Current Opinion in Cardiology
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term follow-up of the first patients to undergo transcatheter alcohol septal ablation.

Cardiology·2010
Same author

Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.

International journal of stroke : official journal of the International Stroke Society·2010
Same author

The role of the sizing balloon in selection of the patent foramen ovale closure device size.

Experimental and clinical cardiology·2008
Same author

Angiographic documented dobutamine induced coronary spasm successfully treated by stenting.

Heart (British Cardiac Society)·2006
Same author

Not all statins interfere with clopidogrel during antiplatelet therapy.

European journal of clinical investigation·2005
Same author

[The contribution of molecular genetics to clinical cardiology: the example of hypertrophic cardiomyopathy].

Revue medicale suisse·2005

New cardiovascular technologies like atherectomy, laser treatments, and stents are under investigation. Limited trials hinder comparisons, risking inappropriate use of unproven tools over standard balloon angioplasty.

Area of Science:

  • Cardiovascular Interventions
  • Medical Technology Assessment

Background:

  • Emerging endovascular technologies are increasingly utilized and evaluated in clinical trials.
  • A paucity of high-quality comparative trials exists for these novel devices.
  • This has led to concerns regarding the potential inappropriate application of unproven technologies.

Purpose of the Study:

  • To review new cardiovascular technologies currently in formal trials.
  • To categorize these technologies based on their therapeutic role.
  • To highlight the need for evidence-based selection of interventional tools.

Main Methods:

  • Literature review focusing on new technologies undergoing formal trials.
  • Categorization of technologies into mechanical removal, high-energy removal, and intraluminal scaffolding.

Related Experiment Videos

  • Analysis of the intended function and potential benefits/risks of each category.

    • Main Results:

    • New technologies are broadly classified into mechanical atherectomy (directional, extractional, rotational), laser atherectomy, and stent-based scaffolding (balloon-expandable, self-expanding, removable).
    • These technologies aim to debulk lesions, remove atheromatous material, or provide vessel support.
    • The efficacy and safety compared to traditional balloon angioplasty remain under investigation due to limited comparative data.

    Conclusions:

    • The review categorizes new endovascular technologies for lesion treatment and support.
    • A critical need exists for robust clinical trials to validate the efficacy and safety of these emerging tools.
    • Judicious use of these technologies, supported by evidence, is crucial to avoid suboptimal patient outcomes.